Inhibition of diverse opportunistic viruses by structurally optimized retrograde trafficking inhibitors.

ABSTRACT: Opportunistic viruses are a major problem for immunosuppressed individuals, particularly following organ or stem cell transplantation. Current treatments are non-existent or suffer from problems such as high toxicity or development of resistant strains. We previously published that a trafficking inhibitor that targets a host protein greatly reduces the replication of human cytomegalovirus. This inhibitor was also shown to be moderately effective against polyomaviruses, another family of opportunistic viruses. We have developed a panel of analogues for this inhibitor and have shown that these analogues maintain their high efficacy against HCMV, while substantially lowering the concentration required to inhibit polyomavirus replication. By targeting a host protein these compounds are able to

SUBMITTER: Desai D 

PROVIDER: S-EPMC7050290 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature